ENTREVESTOR – Densitas Joins Nuance Marketplace

by Shana Cristoferi | Oct 23, 2019 | Densitas Inc., News

See original Entrevestor article here Halifax-based Densitas Inc. whose software helps assess the density of breasts during mammograms, announced this week its densitas densityai software will soon be available on the Nuance AI Marketplace. In a statement, Densitas...

Densitas Software Wins Procurement For DIMASOS Breast Screening Trial In Germany

by Shana Cristoferi | Sep 23, 2019 | Densitas Inc., News

See original news release here Announcing our densitas densityai™ software will be deployed in up to 24 clinics throughout Germany as part of a procurement for a major breast cancer screening trial. Our software will be used to provide breast density measurements at...

ENTREVESTOR: IMV Inc. entering a crucial phase in late 2019

by Shana Cristoferi | Sep 13, 2019 | News

Read original article here IMV Inc., the Dartmouth company developing a delivery platform for immunotherapy drugs, is entering a critical phase of its 16-year history as it will soon learn the results of key Phase 2 clinical trials. The company is conducting a range...

Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million

by Shana Cristoferi | Sep 11, 2019 | News

Read original news release here — Transaction continues to advance Mallinckrodt’s strategic focus on branded biopharmaceuticals by monetizing a non-core business — — H.I.G. Capital to support BioVectra leadership and its attractive growth plan...

IMV Announces Research Collaboration with The Wistar Institute to Develop New Targeted Immunotherapy Against the Common BRAF Cancer Mutation

by Shana Cristoferi | Sep 5, 2019 | IMV Inc., News

Read original article here September 4, 2019 at 7:05 AM EDT DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–Sep. 4, 2019– IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage immuno-oncology company, today announced a collaboration with The Wistar Institute and...